¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"transfer agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • passive transfer
    ¼öµ¿Àü´Þ
  • resistance transfer factor
    ³»¼ºÀü´ÞÀÎÀÚ
  • tendon transfer
    ÈûÁÙÀüÀÌ(¼ú), °ÇÀüÀÌ(¼ú)
  • zygote intrafallopian transfer
    Á¢ÇÕÀÚÀڱðü³»À̽Ä, Á¢ÇÕüÀڱðü³»Àü´Þ
  • anorectic agent
    ½Ä¿å¾ïÁ¦Á¦
  • antiallergic agent
    ¾Ë·¹¸£±â¾à
  • antiarrhythmic agent
    Ç׺ÎÁ¤¸ÆÁ¦
  • antiasthmatic agent
    Ç×õ½ÄÁ¦
  • antifoaming agent
    Ç×±âÆ÷Á¦, ±âÆ÷Á¦°ÅÁ¦
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antiinflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • antimetabolic agent
    Ç×´ë»ç¹°Áú
  • antitumor agent
    Ç×¾ÏÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hyperosmotic agent
    °í»ïÅõ¾ÐÁ¦
  • induction agent
    À¯µµ¹°Áú
  • infectious agent
    °¨¿°Ã¼, °¨¿°¿ø
  • oxidizing agent
    »êÈ­Á¦
  • pressor agent
    ½Â¾ÐÁ¦, Ç÷¾Ð»ó½ÂÁ¦
  • sclerosing agent
    °æÈ­Á¦
  • tocolytic agent
    ÀڱüöÃà¾ïÁ¦Á¦
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • linear energy transfer radiation
    ¼±»ó¿¡³ÊÁöÀüȯ
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • magnetization transfer suppression
    ÀÚ±âÈ­Àü´Þ¾ïÁ¦
  • magnetization transfer technique
    ÀÚ¼ºÈ­Àü´Þ±â¼ú
  • massetric muscle transfer
    ±ú¹°±ÙÀüÀ̼ú
  • microneurovascular muscle transfer
    ¹Ì¼¼½Å°æÇ÷°ü±ÙÀ°ÀüÀ̼ú
  • microvascular transfer
    ¹Ì¼¼Ç÷°üÀüÀÌ
  • myoblast transfer therapy
    ±ÙÀ°¸ð¼¼Æ÷ÀüÀÌ¿ä¹ý
  • nerve pedicle transfer
    ½Å°æÁÙ±âÀ̽Ä
  • passive transfer
    ¼öµ¿Àü´Þ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • placental transfer
    ŹÝÀ̵¿(÷ÃÚïì¹ÔÑ)
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
  • Eaton agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ°º´¿øÃ¼.
  • Eatons agent
    ÀÌÆ° º´¿øÃ¼
  • Eatons agent pneumonia
    ÀÌÆ°º´¿øÃ¼Æó·Å.
  • Norwalk agent
    ³ë¿öÅ© º´¿øÃ¼
  • Norwalk-like agent
    ³ë¸£¿ÍÅ©¾ç ü
  • Parvovirus-like agent
    ÆÄº¸¹ÙÀÌ·¯½º¾ç º´¿øÃ¼
  • Pittsburgh pneumonia [agent]
    ÇÇÃ÷¹ö±×Æó·Å(¿øÀÎü), ·¹Áö¿À³Ú¶óÁõ(¿øÀÎü)
  • addition agent
    ÷°¡Á¦(ôÕÊ¥ð¥).
  • alpha-sympathomimetic agent
    ¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶ÃëÁ¦.
  • anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gene transfer
    À¯ÀüÀÚÀü´Þ.
  • heat transfer =h. transmission
    ¿­Àü´Þ(æðîîÓ¹).
  • heat transfer =h. transmission
    ¿­Àü´Þ(ËçËøËÀ).
  • heat transfer rate
    ¿­Àü´Þ·ü(¡­ëÒ).
  • heat transfer rate
    ¿­Àü´Þ·ü(ÊÙËô).
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • intermolecular H transfer
    ºÐÀÚ°£¼ö¼ÒÀü´Þ(¡­â©áÈîîÓ¹).
  • intramolecular H transfer
    ºÐÀÚ³»¼ö¼ÒÀü´Þ.
  • leucocyte transfer
    ¹éÇ÷±¸Àü´Þ(¡­îîÓ¹).
  • linear energy transfer
    ¼±»ó¿¡³ÊÁö Àü´Þ(àÊßÒ¡­ îîÓ¹)
  • linear energy transfer coefficient
    ¼±Çü¿¡³ÊÁöÀüÀ̰è¼ö
  • magnetic transfer contrast (MTC)
    ÀÚÈ­ Àü´Þ ´ëÁ¶µµ
  • magnetisation transfer coherence
    ÀÚÈ­ Àü´Þ °áÁý
  • magnetization transfer (MT) imaging
    ÀÚÈ­ Àü´Þ ¿µ»ó
  • magnetization transfer effect
    ÀÚÈ­ Àü´Þ È¿°ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • emulsifying agent
    ¿¡¸ÖÁ¯È­Á¦(ûùð¥)
  • F agent
    F Á¦(ð¥)
  • fusogenic agent
    À¶ÇÕ »ý¼ºÁ¦(ë×ùêßæà÷ð¥)
  • germicidal agent
    »ì±ÕÁ¦(߯жð¥)
  • immunosuppressive agent
    ¸é¿ª¾ï¾ÐÁ¦(Øóæ¹åääâð¥)
  • lipotropic agent
    ÁöÁúµ¿¿øÁ¦(ò·òõÔÑê¬ð¥)
  • lympholytic agent
    ¸²ÇÁ±¸¿ëÇØÁ¦(éÁú°ð­)
  • lysosomotropic agent
    ¶óÀ̼ÒÁ»ÀÚ±ØÁ¦(í©Ð»ð¥)
  • methylating agent
    ¸ÞƿȭÁ¦(ð¥)
  • mutagenic agent
    º¯ÀÌ¿øÁ¦(ܨì¶ê«ð¥)
  • oxidizing agent
    »êÈ­Á¦(ß«ûùð¥)
  • precipitating agent
    ħ°­Á¦(öØË½ð¥)
  • pressor agent
    Ç÷¾Ð»ó½ÂÁ¦(úìäâß¾ã°ð¥)
  • reducing agent
    ȯ¿ø ½Ã¾à(ü½êªãËå·)
  • sequestering agent
    °ÝÀýÇü¼ºÁ¦(̰ï¾û¡à÷ð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anabolic agent
    µ¿È­¾à¹°
  • antitumor agent
    Ç׾Ͼà, Á¦¾Ï¾à
  • bleaching agent
    Ç¥¹éÁ¦
  • causative agent
    º´¿øÃ¼, ¿øÀι°Áú
  • chelating agent
    ŰÀÏ·¹ÀÌÆ®¾à
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦
  • contrast agent
    Á¶¿µÁ¦
  • diagnostic agent
    Áø´Ü¿ë¾à
  • etiologic agent
    º´ÀÎü
  • gadolinium based contrast agent
    °¡µ¹¸®´½Á¶¿µÁ¦
  • immunosuppressive agent
    ¸é¿ª¾ïÁ¦¾à, ¸é¿ª¾ïÁ¦ÀÎÀÚ
  • paramagnetic agent
    »óÀÚ¼ºÁ¦Àç
  • protective agent
    º¸È£¾à, ÇÇÆ÷¾à
  • radioopaque agent
    ¹æ»ç¼±ºñÅõ°ú¼ºÁ¦Àç
  • radioprotective agent
    ¹æ»ç¼±¹æÈ£Á¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HDV Hepatitis D(elta) Virus
  = HBV associated Delta Agent
AAA abdominal aortic aneurysm/aneurysmectomy; acne-associated arthritis; acquired aplastic anemia; acute...
AAC antibiotic-associated [pseudomembranous] colitis; antimicrobial agent-induced colitis; augmentative ...
AAT Aachen Aphasia Test; academic aptitude test; alanine aminotransferase; alkylating agent therapy; alp...
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
UCA ultrasound contrast agent
AA alkylating agent
BCA bifunctional chelating agent
CA contrast agent
CPA cryoprotective agent
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • transfer factor
    Àü´Þ ÀÎÀÚ, ÀüÀÌ ¿äÀÎ
  • transfer RNA
    Àü´Þ RNA
  • abetting agent
    Á¶Àå¹°
    ÁÖ ¾à¹°ÀÇ ¾àÈ¿¸¦ º¸Á¶Çϰí, ÁÖ ¾à¹°ÀÇ À¯ÇØÇÑ ÀÛ¿ëÀ» ¸·°Å³ª ¿ÏÈ­ÇÏ´Â ¸ñÀûÀ¸·Î »ç¿ëÇÏ´Â ¾à¹°.
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸° Â÷´ÜÁ¦
    ¾Æµå·¹³¯¸°¼º ¼ö¿ëü¿¡ ÀÛ¿ëÇÏ¿© ½Å°æ Àü´Þü¿Í ¼ö¿ëü°¡ °áÇÕÇÏÁö ¸øÇÏ°Ô ÇÔÀ¸·Î½á ±³°¨½Å°æ ÈïºÐ È¿°ú¸¦ ºÀ¼âÇÏ´Â ¾à¹°.
  • agent
    ¾à¹°, ¾à¹°Á¦, ÀÛ¿ë¹°Áú, º´ÀÎ
    ¹°¸®Àû, È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • anabolic agent
    µ¿È­ ¾à¹°
  • analgesic agent
    ÁøÅëÁ¦
    ½Å°æÀ» ¸¶ºñ½ÃÄÑ ¾ÆÇÄÀ» ÁøÁ¤½ÃŰ´Â ¾àÁ¦. ¸ôÇÉ, ¾ÈƼÇǸ° µîÀÌ ÀÖ´Ù.
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶Ãë, ¸¶ÃëÁ¦
    µ¿ÀǾî=anesthetic drug.
  • anorexigenic agent
    ½Ä¿å ¾ïÁ¦Á¦
  • anti-inflammatory agent
    Ç׿°Áõ ¾à, ¼Ò¿°Á¦, Ç׿°ÁõÁ¦
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦.
  • anti-viral agent
    Ç×¹ÙÀÌ·¯½ºÁ¦
    ¹ÙÀÌ·¯½º¸¦ º´¿øÃ¼·Î ÇÏ´Â Áúº´. Áï, Æ®¶óÄÚ¸¶¡¤¼Ò¾Æ¸¶ºñ
  • antiallergic agent
    Ç׾˷¹¸£±â ¾à
  • anticariogenic agent
    Ç׿ì½Ä¼º ¾à, Ç׿ì½Ä¼º ÀÎÀÚ
    ¿ì½Ä ¿¹¹æ¿¡ È¿°ú°¡ ÀÖ´Â ¾àÁ¦.
  • antifibrinolytic agent
    Ç×¼¶À¯¼Ò ¿ëÇØÁ¦
  • antifoaming agent
    ¼ÒÆ÷Á¦
    µ¿ÀǾî=defoaming.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
RNA, transfer, amino acyl Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl trna synthetase. They are key compounds in the genetic translation process.
(12 Dec 1998)
RNA, transfer, arg A transfer RNA which is specific for carrying arginine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, asn A transfer RNA which is specific for carrying asparagine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, asp A transfer RNA which is specific for carrying aspartic acid to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, cys A transfer RNA which is specific for carrying cysteine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, gln A transfer RNA which is specific for carrying glutamine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, glu A transfer RNA which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, gly A transfer RNA which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, his A transfer RNA which is specific for carrying histidine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, ile A transfer RNA which is specific for carrying isoleucine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, leu A transfer RNA which is specific for carrying leucine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, lys A transfer RNA which is specific for carrying lysine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, met A transfer RNA which is specific for carrying methionine to sites on the ribosomes in preparation for protein elongation. Initiation of protein synthesis uses trna(f)met in prokaryotic cells and trna(I)met in eukaryotic cells.
(12 Dec 1998)
RNA, transfer, phe A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, pro A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transfer tax
    »ó¼Ó¼¼;¾çµµ¼¼
  • agent
    ´ë¸®ÀÎ
  • Eaton agent
    (ÀÇ)ÀÌÆ° ÀÎÀÚ
  • Indian agent
    (¹Ì ij³ª´Ù)Àεð¾ð °ü¸®°ü
  • ad agent
    ±¤°í ´ëÇà¾÷ÀÚ
  • agent
    ´ë¸®ÀÎ;ÁÖ¼±ÀÎ;ÇàÀ§ÀÚ;ÀÛÀÎ
  • book agent
    ¼­Àû¿ÜÆÇ¿ø
  • business agent
    ¾÷¹«´ë¸®
  • commission agent
    °Å°£²Û;Á߸ÅÀÎ;»ç¼³ ¸¶±ÇÀå¼ö
  • consular agent
    ¿µ»ç ´ë¸®
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • county agent
    (¿¬¹æ.ÁÖÁ¤ºÎ°¡ ÆÄ°ßÇÑ)³ó»ç °í¹®
  • double agent
    ÀÌÁß °£Ã¸
  • estate agent
    ºÎµ¿»ê°ü¸®ÀÎ;Áß°³¾÷ÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á